2-Amino-4-(3,4-difluorophenyl)thiazole: Properties & Uses
2-Amino-4-(3,4-difluorophenyl)thiazole: Properties & Uses
2-Amino-4-(3,4-difluorophenyl)thiazole is a fluorinated aminothiazole heterocycle widely employed as a synthetic building block and pharmacophore scaffold in medicinal chemistry and drug-discovery research.
- IUPAC Name
- 4-(3,4-difluorophenyl)-1,3-thiazol-2-amine
- Molecular Formula
- C₉H₆F₂N₂S
- Molecular Weight
- 212.22 g/mol
- Core Scaffold
- 1,3-Thiazole with 2-amino and 4-aryl substituents
- Key Functional Groups
- Primary amine (–NH₂), thiazole ring, 3,4-difluorophenyl arene
- SKU
- A182118
- Supplier
- Aladdin Scientific
Chemical Structure and Physical Properties
2-Amino-4-(3,4-difluorophenyl)thiazole (CAS registry; molecular formula C₉H₆F₂N₂S; MW 212.22 g/mol) belongs to the 2-aminothiazole class of 1,3-heterocycles. The molecule comprises three distinct structural domains: a 1,3-thiazole ring, a primary amino group at the 2-position, and a 3,4-difluorophenyl substituent at the 4-position.
The electron-withdrawing fluorine atoms at the meta and para positions of the pendant phenyl ring significantly modulate the electronic density of the aromatic system, lowering the HOMO energy and increasing lipophilicity relative to the unsubstituted phenyl analogue. The 2-amino group confers hydrogen-bond donor capacity and serves as a handle for further chemical elaboration via acylation, sulfonylation, or condensation reactions. Together, these features make the compound a versatile intermediate for constructing more complex drug-like molecules.
The compound is expected to be a solid at room temperature, consistent with other aryl-substituted aminothiazoles of comparable molecular weight. Stability under standard laboratory storage conditions (cool, dry, away from light) is anticipated. Exact melting point and solubility data should be confirmed from the Certificate of Analysis supplied with each lot.
Synthesis and Synthetic Utility
2-Aminothiazoles are classically prepared via the Hantzsch thiazole synthesis, in which an α-haloketone is condensed with thiourea under mild acidic conditions. For 2-Amino-4-(3,4-difluorophenyl)thiazole, the corresponding route employs 3,4-difluorophenacyl bromide (or an equivalent α-haloketone bearing the 3,4-difluorophenyl group) reacted with thiourea to furnish the 2-amino-4-arylthiazole product directly.
As a synthetic building block, the compound offers multiple sites for downstream diversification:
- Amino group functionalization: The –NH₂ at C-2 can be acylated with acid chlorides or anhydrides, reacted with isocyanates to give ureas, coupled with sulfonyl chlorides to form sulfonamides, or engaged in reductive amination sequences.
- Ring elaboration: Electrophilic substitution at C-5 of the thiazole ring is feasible under appropriate conditions, enabling introduction of halogens or other electrophiles.
- Cross-coupling: Halogenation at C-5 followed by palladium-catalyzed cross-coupling (Suzuki, Buchwald–Hartwig) allows access to highly substituted thiazole libraries.
These pathways make the compound an efficient entry point into structurally diverse aminothiazole libraries for high-throughput screening campaigns.
Research and Medicinal Chemistry Applications
The 2-aminothiazole motif is a privileged scaffold in medicinal chemistry, appearing in numerous bioactive compounds and approved pharmaceuticals. Its ability to act simultaneously as a hydrogen-bond acceptor (thiazole nitrogen) and donor (2-NH₂) facilitates productive binding interactions with enzyme active sites and receptor binding pockets.
The incorporation of a 3,4-difluorophenyl group is a particularly common strategy in drug design for several reasons:
- Metabolic stability: Fluorine substitution at positions vulnerable to cytochrome P450-mediated oxidation blocks metabolic hydroxylation, potentially improving in vivo half-life.
- Binding affinity: Fluorine's strong electronegativity and small van der Waals radius allow tight packing within hydrophobic binding pockets and participation in orthogonal multipolar interactions with carbonyl groups or aromatic rings of target proteins.
- Physicochemical tuning: The difluoro substitution modulates pKa of adjacent functional groups and overall lipophilicity (logP), aiding optimization of ADMET properties.
Researchers working on kinase inhibitors, antimicrobial agents, anti-inflammatory compounds, and CNS-active molecules have employed structurally related fluorinated aminothiazole scaffolds. 2-Amino-4-(3,4-difluorophenyl)thiazole (A182118) is therefore of interest as a starting material or intermediate in lead identification and lead optimization programs.
Handling, Storage, and Safety Considerations
As with all fine-chemical reagents, appropriate laboratory safety practices should be followed when handling 2-Amino-4-(3,4-difluorophenyl)thiazole. Users should consult the product-specific Safety Data Sheet (SDS) available from Aladdin Scientific before use.
General handling guidance:
- Use personal protective equipment (PPE) including chemical-resistant gloves, laboratory coat, and eye protection.
- Handle in a well-ventilated fume hood to minimize inhalation exposure to fine particulates.
- Avoid contact with skin, eyes, and mucous membranes.
Storage recommendations:
- Store in a tightly sealed container in a cool (typically 2–8 °C or as specified on the product label), dry location away from direct light and incompatible materials.
- Keep away from strong oxidizing agents and strong acids.
- Check the Certificate of Analysis (CoA) for lot-specific purity, appearance, and storage instructions.
Disposal: Dispose of waste in accordance with local, regional, and national regulations governing hazardous chemical waste. Do not dispose of down drains or into the environment.
Frequently asked questions
What is the molecular formula and molecular weight of 2-Amino-4-(3,4-difluorophenyl)thiazole?
The molecular formula of 2-Amino-4-(3,4-difluorophenyl)thiazole is C₉H₆F₂N₂S and its molecular weight is 212.22 g/mol. These values reflect the thiazole core, the 2-amino substituent, and the 3,4-difluorophenyl group at position 4.
How can the 2-amino group of this thiazole be functionalized for library synthesis?
The primary amine at the 2-position can be derivatized through several reactions: acylation with acid chlorides or anhydrides to give amides, reaction with isocyanates to form ureas, coupling with sulfonyl chlorides to produce sulfonamides, or condensation with aldehydes followed by reduction for reductive amination. These transformations make it straightforward to generate diverse compound libraries from this single scaffold.
Why is the 3,4-difluorophenyl group strategically important in drug design?
The 3,4-difluorophenyl moiety is widely used in medicinal chemistry because fluorine atoms improve metabolic stability by blocking cytochrome P450-mediated oxidation at vulnerable aromatic positions. Additionally, fluorine's high electronegativity enables favorable multipolar interactions with target proteins and allows fine-tuning of the compound's lipophilicity and pKa, supporting optimization of pharmacokinetic and pharmacodynamic properties.
What are the recommended storage conditions for A182118?
A182118 should be stored in a tightly sealed container under cool, dry conditions away from direct light, consistent with standard practice for aminothiazole building blocks. Users should refer to the product label and Certificate of Analysis for lot-specific storage temperature recommendations and confirm conditions with the Aladdin Scientific SDS.
Is 2-Amino-4-(3,4-difluorophenyl)thiazole suitable as a pharmacophore scaffold for kinase inhibitor discovery?
The 2-aminothiazole scaffold is well-established as a pharmacophore in kinase inhibitor programs, where the amino and ring nitrogen atoms mimic the hinge-binding interactions of ATP. The 3,4-difluorophenyl group at C-4 can project into hydrophobic regions of the ATP-binding site, while the amino group allows further elaboration to introduce selectivity-determining elements. However, specific biological activity data for this exact compound should be generated experimentally and are not guaranteed by structural analogy alone.
References
- Hantzsch, A.; Weber, J. H. Ueber Verbindungen des Thiazols (Pyridins der Thiophenreihe). Ber. Dtsch. Chem. Ges. 1887, 20, 3118–3132.
- Gomtsyan, A. Heterocycles in drugs and drug discovery. Chem. Heterocycl. Compd. 2012, 48, 7–10.
- Müller, K.; Faeh, C.; Diederich, F. Fluorine in pharmaceuticals: looking beyond intuition. Science 2007, 317, 1881–1886. doi:10.1126/science.1131943
- Gillis, E. P.; Eastman, K. J.; Hill, M. D.; Donnelly, D. J.; Meanwell, N. A. Applications of fluorine in medicinal chemistry. J. Med. Chem. 2015, 58, 8315–8359. doi:10.1021/acs.jmedchem.5b00258
Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.
危险品化学品经营许可证(带存储)